Chairman emeritus Peter C. Farrell - 31 Oct 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Director
Signature
Peter C. Farrell, Chairman
Issuer symbol
RMD
Transactions as of
31 Oct 2022
Net transactions value
-$2,008,877
Form type
4
Filing time
02 Nov 2022, 17:23:04 UTC
Previous filing
06 Sep 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $2,008,877 -9,050 -4.7% $221.98 183,052 31 Oct 2022 Direct F1
transaction RMD ResMed Common Stock Gift $0 -4,550 -2.5% $0.000000 178,502 31 Oct 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $217.65 to $224.11. The price reported above reflects the weighted average sale price.
F2 Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Unitrust. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.